All-cause survival estimates compared to observed survival in older women with breast cancer in CALGB 49907 and 369901 (Alliance A151503)

被引：1
|
作者：
Kimmick, G.
Pitcher, B.
Mandelblatt, J.
Clapp, J.
Balman, K.
Barginear, M.
Freedman, R.
Artz, A.
Klepin, H.
Lafky, J.
Hopkins, J.
Winer, E.
Hudis, C.
Muss, H.
Cohen, H.
Jatoi, A.
Hurria, A.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Georgetown Univ, Washington, DC 20057 USA
[3] North Shore Hlth Syst, New York, NY USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Univ Chicago, Chicago, IL 60637 USA
[6] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
[7] Mayo Clin, Jacksonville, FL USA
[8] Forsyth Reg Canc Ctr, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, New York, NY USA
[10] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P6-09-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-09-10
引用
收藏
页数：2
相关论文
共 12 条
  • [1] Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)
    Kimmick, Gretchen G.
    Major, Brittny
    Clapp, Jonathan
    Sloan, Jeff
    Pitcher, Brandelyn
    Ballman, Karla
    Barginear, Myra
    Freedman, Rachel A.
    Artz, Andrew
    Klepin, Heidi D.
    Lafky, Jacqueline M.
    Hopkins, Judith
    Winer, Eric
    Hudis, Clifford
    Muss, Hyman
    Cohen, Harvey
    Jatoi, Aminah
    Hurria, Arti
    Mandelblatt, Jeanne
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (02) : 391 - 398
  • [2] Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)
    Gretchen G. Kimmick
    Brittny Major
    Jonathan Clapp
    Jeff Sloan
    Brandelyn Pitcher
    Karla Ballman
    Myra Barginear
    Rachel A. Freedman
    Andrew Artz
    Heidi D. Klepin
    Jacqueline M. Lafky
    Judith Hopkins
    Eric Winer
    Clifford Hudis
    Hyman Muss
    Harvey Cohen
    Aminah Jatoi
    Arti Hurria
    Jeanne Mandelblatt
    [J]. Breast Cancer Research and Treatment, 2017, 163 : 391 - 398
  • [3] Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907
    Muss, Hyman B.
    Berry, Donald A.
    Cirrincione, Constance T.
    Theodoulou, Maria
    Hurria, Arti
    Cohen, Harvey Jay
    Partridge, Ann
    Norton, Larry
    Hudis, Clifford A.
    Winer, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)
    Klepin, Heidi D.
    Pitcher, Brandelyn N.
    Ballman, Karla V.
    Kornblith, Alice B.
    Hurria, Arti
    Winer, Eric P.
    Hudis, Clifford
    Cohen, Harvey J.
    Muss, Hyman B.
    Kimmick, Gretchen G.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (05) : E285 - E292
  • [5] Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance]
    Gajra, Ajeet
    McCall, Linda
    Muss, Hyman B.
    Cohen, Harvey J.
    Jatoi, Aminah
    Ballman, Karla V.
    Partridge, Ann H.
    Sutton, Linda
    Parker, Barbara A.
    Magrinat, Gustav
    Lafky, Jaqueline M.
    Hurria, Arti
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Association between neighborhood disinvestment and all-cause survival moderated by epigenetic age among women with breast cancer
    Plascak, Jesse J.
    Archer, Kellie
    Llanos, Adana A.
    Mooney, Stephen J.
    Xing, Cathleen Y.
    Rundle, Andrew G.
    Zarbl, Helmut
    Qin, B.
    Zeinomar, Nur
    Schootman, Mario
    Yao, Song
    Ambrosone, Christine
    Pawlish, Karen
    Demissie, Kitaw
    Bandera, Elisa V.
    Hong, Chi-Chen
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [7] Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907
    Lichtman, Stuart M.
    Cirrincione, Constance T.
    Hurria, Arti
    Jatoi, Aminah
    Theodoulou, Maria
    Wolff, Antonio C.
    Gralow, Julie
    Morganstern, Daniel E.
    Magrinat, Gustav
    Cohen, Harvey Jay
    Muss, Hyman B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 699 - +
  • [8] Influence of guideline-concordant adjuvant therapy on all-cause and disease-specific survival among breast cancer patients in rural Georgia
    Guy, Gery P.
    Gillespie, Theresa Wicklin
    Goodman, Michael
    Richardson, Lisa Carolyn
    Ward, Kevin C.
    Lipscomb, Joseph
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Elevated breast cancer mortality in young women (<40 years) compared with older women is attributed to poorer survival in early-stage disease
    Gnerlich, Jennifer
    Deshpande, Anjali D.
    Jeffe, Donna B.
    Sweet, Allison
    White, Nick
    Margenthaler, Julie A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S79 - S79
  • [10] Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease
    Gnerlich, Jennifer L.
    Deshpande, Anjali D.
    Jeffe, Donna B.
    Sweet, Allison
    White, Nick
    Margenthaler, Julie A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (03) : 341 - 347
12